Literature DB >> 7326022

The rôle of mitochondrial pyruvate transport in the stimulation by glucagon and phenylephrine of gluconeogenesis from L-lactate in isolated rat hepatocytes.

A P Thomas, A P Halestrap.   

Abstract

The sensitivity of glucose production from L-lactate by isolated liver cells from starved rats to inhibition by alpha-cyano-4-hydroxycinnamate was studied. A small percentage of the maximal rate of gluconeogenesis was insensitive to inhibition by alpha-cyano-4-hydroxycinnamate, and evidence is presented to show that this is due to pyruvate entry into the mitochondria as alanine. After subtraction of this rate, Dixon plots of the reciprocal of the rate of gluconeogenesis against inhibitor concentration were linear both in the absence and presence of glucagon, phenylephrine or valinomycin, each of which stimulated gluconeogenesis by 30-50%. Pyruvate kinase activity was decreased by glucagon, but not by phenylephrine or valinomycin. Inhibition of gluconeogenesis by quinolinate (inhibitor of phosphoenolpyruvate carboxykinase) or monochloroacetate (probably inhibiting pyruvate carboxylation) caused a significant deviation from linearity of the Dixon plot obtained with alpha-cyano-4-hydroxycinnamate. Amytal, however, inhibited gluconeogenesis without affecting the linearity of this plot. These data, coupled with a computer simulation study, suggest that pyruvate transport may control gluconeogenesis from L-lactate and that hormones may stimulate this process through an effect on the respiratory chain. An additional role for pyruvate kinase and pyruvate carboxylase is quite compatible with the data presented.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7326022      PMCID: PMC1163301          DOI: 10.1042/bj1980551

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  Hormonal regulation of liver mitochondrial pyruvate carrier in relation to gluconeogenesis and lipogenesis.

Authors:  M A Titheradge; H G Coore
Journal:  FEBS Lett       Date:  1976-11-15       Impact factor: 4.124

2.  Metabolic implications of the distribution of the alanine aminotransferase isoenzymes.

Authors:  G DeRosa; R W Swick
Journal:  J Biol Chem       Date:  1975-10-25       Impact factor: 5.157

3.  The involvement of mitochondrial pyruvate transport in the pathways of gluconeogenesis from serine and alanine in isolated rat and mouse liver cells.

Authors:  J Mendes-Mourāo; A P Halestrap; D M Crisp; C I Pogson
Journal:  FEBS Lett       Date:  1975-04-15       Impact factor: 4.124

4.  Cyclic AMP induced inhibition of pyruvate kinase flux in the intact liver cell.

Authors:  R Rognstad
Journal:  Biochem Biophys Res Commun       Date:  1975-04-21       Impact factor: 3.575

5.  The mitochondrial pyruvate carrier, its exchange properties and its regulation by glucagon.

Authors:  M A Titheradge; H G Coore
Journal:  FEBS Lett       Date:  1976-03-15       Impact factor: 4.124

6.  The stimulatory effect of glucagon and dibutyryl cyclic AMP on ureogenesis and gluconeogenesis in relation to the mitochondrial ATP content.

Authors:  J Bryla; E J Harris; J A Plumb
Journal:  FEBS Lett       Date:  1977-08-15       Impact factor: 4.124

7.  The mechanism of the inhibition of the mitochondrial pyruvate transportater by alpha-cyanocinnamate derivatives.

Authors:  A P Halestrap
Journal:  Biochem J       Date:  1976-04-15       Impact factor: 3.857

8.  Permeability of the liver cell membrane to quinolinate.

Authors:  K R Elliott; C I Pogson; S A Smith
Journal:  Biochem J       Date:  1977-04-15       Impact factor: 3.857

9.  Studies on the alpha-andrenergic activation of hepatic glucose output. II. Investigation of the roles of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in the actions of phenylephrine in isolated hepatocytes.

Authors:  A D Cherrington; F D Assimacopoulos; S C Harper; J D Corbin; C R Park; J H Exton
Journal:  J Biol Chem       Date:  1976-09-10       Impact factor: 5.157

10.  The specificity and metabolic implications of the inhibition of pyruvate transport in isolated mitochondria and intact tissue preparations by alpha-Cyano-4-hydroxycinnamate and related compounds.

Authors:  A P Halestrap; R M Denton
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

View more
  9 in total

1.  Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling.

Authors:  Kyle S McCommis; Zhouji Chen; Xiaorong Fu; William G McDonald; Jerry R Colca; Rolf F Kletzien; Shawn C Burgess; Brian N Finck
Journal:  Cell Metab       Date:  2015-09-03       Impact factor: 27.287

Review 2.  Mitochondrial pyruvate transport: a historical perspective and future research directions.

Authors:  Kyle S McCommis; Brian N Finck
Journal:  Biochem J       Date:  2015-03-15       Impact factor: 3.857

Review 3.  Including the mitochondrial metabolism of L-lactate in cancer metabolic reprogramming.

Authors:  Lidia de Bari; Anna Atlante
Journal:  Cell Mol Life Sci       Date:  2018-05-04       Impact factor: 9.261

4.  Partial reconstruction of in vitro gluconeogenesis arising from mitochondrial l-lactate uptake/metabolism and oxaloacetate export via novel L-lactate translocators.

Authors:  Lidia De Bari; Anna Atlante; Daniela Valenti; Salvatore Passarella
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

5.  Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose-stimulated insulin secretion.

Authors:  Patrick A Vigueira; Kyle S McCommis; George G Schweitzer; Maria S Remedi; Kari T Chambers; Xiaorong Fu; William G McDonald; Serena L Cole; Jerry R Colca; Rolf F Kletzien; Shawn C Burgess; Brian N Finck
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

6.  Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis.

Authors:  Lawrence R Gray; Mst Rasheda Sultana; Adam J Rauckhorst; Lalita Oonthonpan; Sean C Tompkins; Arpit Sharma; Xiaorong Fu; Ren Miao; Alvin D Pewa; Kathryn S Brown; Erin E Lane; Ashley Dohlman; Diana Zepeda-Orozco; Jianxin Xie; Jared Rutter; Andrew W Norris; James E Cox; Shawn C Burgess; Matthew J Potthoff; Eric B Taylor
Journal:  Cell Metab       Date:  2015-09-03       Impact factor: 27.287

7.  The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters.

Authors:  Bethany Nancolas; Lili Guo; Rong Zhou; Kavindra Nath; David S Nelson; Dennis B Leeper; Ian A Blair; Jerry D Glickson; Andrew P Halestrap
Journal:  Biochem J       Date:  2016-02-01       Impact factor: 3.857

Review 8.  Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets.

Authors:  Yadan Chen; Haiming Ma; Dasheng Zhu; Guowei Zhao; Lili Wang; Xiujuan Fu; Wei Chen
Journal:  PPAR Res       Date:  2017-06-04       Impact factor: 4.964

9.  Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation.

Authors:  Tabassum Moonira; Shruti S Chachra; Brian E Ford; Silvia Marin; Ahmed Alshawi; Natasha S Adam-Primus; Catherine Arden; Ziad H Al-Oanzi; Marc Foretz; Benoit Viollet; Marta Cascante; Loranne Agius
Journal:  J Biol Chem       Date:  2020-01-23       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.